Development and testing of messaging to drive adoption and use of HIV prevention products among young, urban and per-urban south african women
Ended Awarded Last action
- Contract number
- 75N93019F00135
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $510,898
Award facts
- Opportunity
-
- NIAIDDAIDSNIHAI2015029 Solicitation number
- Comprehensive Resources for HIV Microbicides and Biomedical Prevention Award Notice · Posted Jun 24, 2015
- Contract value 100% obligated
- $510,898.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $31,175 | |
| Other Administrative Action | $0 | |
| Original award | $479,723 |
About this award
This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to Advanced Bioscience Laboratories, Inc. (ABL). The $510,898.00 contract is for the development and testing of messaging to drive adoption and use of HIV prevention products among young, urban and per-urban South African women.
The contract is a delivery order under the HIV Microbicides and Biomedical Prevention 2016-2021 indefinite-delivery/indefinite-quantity (IDIQ) master contract. ABL is a contract research and manufacturing organization that has been awarded over $35 million in federal contracts to support the development of biologics, including vaccines, for agencies such as the National Institutes of Health and Department of Health and Human Services. This contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N93019F00135?
75N93019F00135 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2019.
How much is contract 75N93019F00135 worth?
The government has obligated $510,898 on 75N93019F00135.
Is contract 75N93019F00135 an order under another contract?
Yes. 75N93019F00135 is a delivery order under HHSN272201600008I, an indefinite delivery contract, on HIV Microbicides and Biomedical Prevention 2016-2021.
Was contract 75N93019F00135 competed?
The extent of competition for 75N93019F00135 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award